Results
2
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARGX | €624.40 | -2.1% | 77.2% | €37.7b | €628.59 | PS20.8x | E41.9% | n/a | Pharmaceuticals & Biotech | ||
UCB | €188.05 | 3.0% | 115.4% | €35.7b | €193.94 | PE148.7x | E28.4% | 0.7% | Pharmaceuticals & Biotech |